COVID AND THE VACCINE - TRUTH, LIES, AND MISCONCEPTIONS REVEALED, page-32971

First 32971 Last

Share
Profile

Follow
peroovial

3,127 Posts.

8

25/02/22

00:01

Post #: 59808413
Share

Originally posted by GCar: ↑

"it is no joke for many of those that contract it."

Define "many".

More weasel-word BS. Straight out of the MSM playbook.

Most people do NOT even know they have contracted it.

The VAST majority do not get severely ill.

The VAST VAST majority* survive it.

*IFR estimates for 2020 indicated a median global survival rate of 99.85% for all ages, and 99.95% for those under 70yrs.

Healthy younger adults?
Healthy Kids?
FFS their mortality risk is effectively zero.

...AND: current IFRs are even better e.g. studies indicating that earlier 99.95% survival rate for under 70yrs could now be 99.995%, or even better still.

I'll ask you the similar questions I asked hoppy EOT:
1/ What was YOUR survival rate estimate pre-jab?
2/ How much do you estimate the jab increased that by/to..?
3/ How did you weigh the risks/benefits, knowing there is ZERO longer-term information on potential health impacts, there is basically zero investigation or knowledge of the risk factors for adverse reactions, and that this was the first mass rollout of this mRNA tech; no precedents, no experience, incomplete clinical trials, severe adverse reaction and death reports worse than every jab in history..?

Surely you have a clear answer to (1) and (2) at least, or did you just "trust the TV experts" like EOT did..?

Expand

You do a better job than most in making logco look the complete fool.
The guy has no sense of shame or embarrassment, just like that other rotten pos, and I don't mean eot.
9 Upvote

Reply

Top Stories

LDX

Lumos Diagnostics surges 140% on major US contract deal

LU7

Lithium Universe targets silver boom with breakthrough solar recycling tech

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

ASX Market Close: Why are we red today? Because US CPI's at 3%

LIS

Li-S Energy the latest microcap to pivot to US defence market